Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBabcock Regulatory News (BAB)

Share Price Information for Babcock (BAB)

Share Price is delayed by 15 minutes
Get Live Data
1,046.00    13.50 (1.31%)
Bid:
1,038.00
Ask:
1,039.00
Spread: 1.00 (0.096%)
Market Cap: £5.12b
BAB Live PriceLast checked at - London Stock Exchange

Intraday Babcock Share Chart

AGM trading update

19 Sep 2024 07:00

RNS Number : 7772E
Babcock International Group PLC
19 September 2024
 

 

 

 

19 September 2024

 

Babcock International Group PLC

 

AGM trading update - encouraging start to the year, FY expectations unchanged

 

Babcock International Group PLC ("Babcock" or "the Group") provides a trading update for the first five months of the financial year ahead of its Annual General Meeting to be held at 10.30 am today.

Trading update

Trading for the five-month period to 31 August 2024 has been encouraging and in line with the Board's expectations.

Positive momentum has continued into H1, and the Group has delivered good organic revenue growth, particularly in civil and naval Nuclear, and in the Land Sector. Group underlying operating profit also increased compared to the same period last year, despite last year including the license fees from the Polish MIECZNIK programme.

Our expectations for the full year are unchanged and we continue to progress toward our medium-term guidance.

Business developments

Demand in our core defence market remains positive and we continue to make good strategic progress. We have:

·

Launched H&B Defence, a joint venture with HII (NYSE: HII) to accelerate the development of critical sovereign capability for Australia's AUKUS nuclear-powered submarine programme, including workforce, nuclear infrastructure design and build, submarine defueling and decommissioning, nuclear waste and future sustainment.

·

Reopened 9 Dock in Devonport on 12 September, following the completion of an extensive regeneration project. The dry dock will deliver the £560 million maintenance programme to extend the operational life of HMS Victorious, currently underway, and is critical for the future support of the UK's Continuous At Sea Deterrent.

·

Inaugurated the Babcock Engineering & Nuclear Skills building at City College Plymouth. Opened by the Minister of State for Defence Procurement and Industry, the new facility will enhance our growing workforce's capabilities in the UK's nuclear programmes.

·

Signed a contract extension with PGZ SA, the Polish Armaments Group, to continue our support to Poland's Miecznik frigate programme until the delivery of ship three in 2031.

 

The Group's HY25 results will be published on 13 November 2024.

 

For further information:

 

Andrew Gollan, Babcock Director of Investor Relations

+44 (0)7936 039 004

Kate Hill, Babcock Group Head of Financial Communications

+44 (0)20 7355 5312

Olivia Peters / Harry Cameron, Teneo

+44 (0)20 7353 4200

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCZZGMLGRGGDZZ
Date   Source Headline
4th Aug 20257:00 amRNSTransaction in Own Shares
1st Aug 202511:36 amRNSTotal Voting Rights
1st Aug 20257:00 amRNSTransaction in Own Shares
31st Jul 202512:02 pmRNSDirector/PDMR Shareholding
30th Jul 20257:00 amRNSTransaction in Own Shares
29th Jul 20255:00 pmRNSNotice of AGM
29th Jul 20257:00 amRNSTransaction in Own Shares
28th Jul 20257:00 amRNSTransaction in Own Shares
25th Jul 20257:00 amRNSTransaction in Own Shares
23rd Jul 20256:27 pmRNSLaunch of Share Buyback Programme
7th Jul 20253:36 pmRNSDirector/PDMR Shareholding
3rd Jul 20253:57 pmRNSDirector/PDMR Shareholding
1st Jul 20255:41 pmRNSFinal Results
25th Jun 20257:00 amRNSPreliminary results for the year ended 31.03.2025
17th Jun 20253:30 pmRNSHolding(s) in Company
10th Jun 20251:11 pmRNSHolding(s) in Company
9th Jun 20254:23 pmRNSDirector Announcement
5th Jun 20259:00 amRNSDirectorate Change
20th May 202512:48 pmRNSBabcock host Cavendish Nuclear teach-in event
23rd Apr 20257:00 amRNSFY25 Post-close Trading Update
26th Mar 20257:30 amRNSBabcock awarded five-year British Army contract
19th Mar 20256:00 pmRNSHargreaves Lansdown
7th Feb 20253:16 pmRNSHolding(s) in Company
6th Feb 20257:00 amRNSQ3 trading update and upgrade of FY25 expectations
30th Jan 20254:05 pmRNSHolding(s) in Company
21st Jan 20253:55 pmRNSDirector/PDMR Shareholding
27th Nov 202411:37 amRNSDirector/PDMR Shareholding
18th Nov 20243:06 pmRNSDirector/PDMR Shareholding
18th Nov 20242:34 pmRNSChange of Record Date for Interim Dividend
14th Nov 20244:33 pmRNSDirector/PDMR Shareholding
14th Nov 202411:50 amRNSDirector announcement
13th Nov 20247:00 amRNSResults for the six months ended 30 September 2024
4th Oct 20242:52 pmRNSDirector/PDMR Shareholding
3rd Oct 20244:13 pmRNSDirector/PDMR Shareholding
1st Oct 20243:04 pmRNSHolding(s) in Company
30th Sep 20243:41 pmRNSDirector/PDMR Shareholding
26th Sep 20242:49 pmRNSDirector/PDMR Shareholding
19th Sep 20243:35 pmRNSResult of AGM
19th Sep 20247:00 amRNSAGM trading update
6th Sep 202411:48 amRNSDirector/PDMR Shareholding
29th Aug 20244:33 pmRNSDirector/PDMR Shareholding - Replacement
29th Aug 20241:26 pmRNSDirector/PDMR Shareholding
15th Aug 20241:01 pmRNSNotice of AGM
7th Aug 20249:44 amRNSDirector/PDMR Shareholding
6th Aug 202411:28 amRNSDirector/PDMR Shareholding
5th Aug 20244:26 pmRNSDirector/PDMR Shareholding
2nd Aug 202412:02 pmRNSDirector/PDMR Shareholding
1st Aug 20243:48 pmRNSDirector/PDMR Shareholding
30th Jul 20249:53 amRNSAnnual Financial Report
26th Jul 20247:00 amRNSFull year results for the year ended 31 March 2024

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.